Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

H2-blockers: how safe and how effective?

H M Spiro

    Journal of Clinical Gastroenterology
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    H2-blockers offer safe and effective short-term treatment for duodenal ulcers, speeding symptom relief and healing. Long-term use shows promise in preventing ulcer recurrence, though further study is needed for broader patient groups.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Response of the Gastrointestinal Tract of the Mouse to 5-Fluorouracil.

    The American journal of pathology·2009
    Same author

    The irritable bowel. 1958.

    Connecticut medicine·2009
    Same author

    A contribution to the debate.

    Advances in mind-body medicine·2000
    Same author

    Hope helps: placebos and alternative medicine in rheumatology.

    Rheumatic diseases clinics of North America·1999
    Same author

    Fat, foreboding, and flatulence.

    Annals of internal medicine·1999
    Same author

    Peptic ulcer: Moynihan's or Marshall's disease?

    Lancet (London, England)·1998
    Same journal

    GLP-1 Receptor Agonists and Hepatic Encephalopathy in Cirrhosis: A Protective Signal Requiring Cancer and Nutritional Phenotyping.

    Journal of clinical gastroenterology·2026
    Same journal

    Endoscopic Incisional Therapy for Benign Esophageal Strictures: A Systematic Review and Meta-Analysis.

    Journal of clinical gastroenterology·2026
    Same journal

    International Consensus Statements on the Use of Topical Endoscopic Hemostatic Powders in the Treatment of Acute Gastrointestinal Bleeding.

    Journal of clinical gastroenterology·2026
    Same journal

    Do Risk Factors for Reflux Symptoms After Peroral Endoscopic Myotomy Necessarily Increase the Occurrence of Postoperative Gastroesophageal Reflux?

    Journal of clinical gastroenterology·2026
    Same journal

    Subgroup Stratification by Regimen, Geography, and Population Is Necessary to Validate Nitazoxanide-based Helicobacter pylori Eradication Therapy.

    Journal of clinical gastroenterology·2026
    Same journal

    The Impact of Glucagon-Like Peptide 1 Receptor Agonists Versus Diabetes Mellitus on Endoscopic Procedures: A Case-Control Study From a Large Tertiary Care Health System.

    Journal of clinical gastroenterology·2026
    See all related articles

    Area of Science:

    • Gastroenterology
    • Pharmacology

    Background:

    • Short-term use of H2-blockers is established as safe and effective for acute duodenal ulcers.
    • Variations in placebo response and efficacy across countries require further investigation but do not negate overall benefits.

    Purpose of the Study:

    • To evaluate the efficacy and safety of H2-blockers in treating acute duodenal ulcers.
    • To assess the role of H2-blockers in preventing duodenal ulcer recurrence.
    • To explore the potential use of H2-blockers for dyspepsia symptoms without a confirmed ulcer.

    Main Methods:

    • Clinical experience and controlled trials were reviewed.
    • Studies focused on endoscopically proven duodenal ulcers.

    Main Results:

    Related Experiment Videos

  • H2-blockers significantly accelerate the healing of acute duodenal ulcers with minimal side effects.
  • Controlled trials demonstrate a high rate of duodenal ulcer recurrence prevention with H2-blockers compared to placebo.
  • Long-term safety and efficacy data are still being evaluated.

    • Conclusions:

    • H2-blockers are a valuable tool for rapid symptom relief and healing of acute duodenal ulcers.
    • Maintenance therapy with H2-blockers is increasingly considered for patients with healed duodenal ulcers.
    • The benefits of H2-blockers may extend to patients with dyspeptic symptoms without confirmed ulcers, warranting further research.